Gwyneth Paltrow has a new morning routine, she revealed at the first ever Goop digital summit over the weekend.
According to British Vogue, Paltrow explained that she starts each day with “a huge glass of celery juice”.
"I don’t set an alarm anymore," the 47-year-old said. "I wake up between 7am and 8am naturally.
"I have a huge glass of celery juice, I do my meditation, then I work out for an hour.”
The actor added that she eats meals as a family with her husband, Glee co-creator Brad Falchuk.
The couple have also made regular walks a part of their weekly routine, Paltrow added.
“Brad and I really try to make time to take a walk three times a week, and we leave our phones at home.”
In another session at the virtual event, Paltrow opened up about her diet.
“My diet is so bad right now, it’s the least Goopy,” she said.
“It’s all grilled cheese, quesadillas, taquitos… it’s fried, it’s gluten, it’s dairy, it’s alcohol.”
The comments come after Goop, Paltrow’s lifestyle brand, was criticised by the head of the NHS.
In January, while delivering a speech at the Sheldonian Theatre, Oxford, Sir Simon Stevens, chief executive of NHS England, highlighted the “dubious wellness products and dodgy procedures” that are available for consumers online.
Sir Simon stressed that the speed at which inaccurate health claims can be spread on the internet has put “myths and misinformation on steroids”.
“Fresh from controversies over jade eggs and unusually scented candles, Goop has just popped up with a new TV series, in which Gwyneth Paltrow and her team test vampire facials and back a ‘bodyworker’ who claims to cure both acute psychological trauma and side effects by simply moving his hands two inches above a customer’s body,” Sir Simon stated.
In a statement sent to The Independent at the time, Goop said it “takes efficacy and product claims very seriously.”
“With the editorial and commercial aspects of our business, we sometimes approach different topics from different points of view.
"On the editorial side, we are transparent when we cover emerging topics that may be unsupported by science or may be in early stages of review,” the company stated.
